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Background: For Medina (0,1,0) and (0,0,1) lesion, stent implantation at ostium of bifurcation may finish with incomplete coverage of lesion and 
may cause proximal edge restenosis. But if we crossover other branch with stent, additional balloon dilatation for healthy vessels through jailed strut 
to maintain access route for other branch with single balloon or kissing balloon technique may be needed. So this study was aimed to investigate 
the outcomes of ostial and crossover stent implantation for Medina (0,1,0) and (0,0,1) bifurcated lesion. 
Methods: From April 2007 to December 2009, total 5036 lesions had PCI, and total 1027 bifurcated lesions were treated at our institution. 
Subject for the study was serial 186 denovo bifurcated lesions classified for Medina (0,1,0) or (0,0,1) and implanted drug-eluting stent (sirolimus-, 
paclitaxel-, zotarolimus-, everolimus-eluting stent). Subject was divided to 2 groups with different stenting techniques, ostial stent group (OS group) 
67 lesions and crossover stent group (CS group) 119 lesions. Primary endpoint was binary restenosis (defined as %diameter stenosis>50% in QCA at 
follow up angiogram, mean 309±186days from PCI) of main vessel (defined as stented vessel) and also target lesion revascularization (TLR) rate of 
each group was calculated. Variables were compared over 2 groups retrospectively. Also multivariate predictors of primary endpoint were calculated. 
Results: Baseline characteristics were similar. Intravascular ultrasounds usage was 63% in OS group and 69% in CS group (p=0.42). In CS group, 
additional balloon dilatation for healthy vessels through jailed strut with single balloon 7% and with kissing balloon technique 63% performed. 
Binary restenosis rate, TLR rate of OS and CS group were 9% vs. 8% (p=1.00), 7% vs. 4% (p=0.50), respectively. Multivariate predictors of primary 
endpoint were post minimum lumen diameter (p=0.02 OR:0.21) and calcified lesion (p=0.04 OR:4.32). 
Conclusion: Ostial stenting technique for Medina (0,1,0) or (0,0,1) bifurcated lesions provided similar outcomes to crossover stenting technique 
which may be acceptable. 
